Tue.Apr 02, 2024

article thumbnail

World's most powerful MRI scans first images of human brain

Medical Xpress: Radiology

The world's most powerful MRI scanner has delivered its first images of human brains, reaching a new level of precision that is hoped will shed more light on our mysterious minds—and the illnesses that haunt them.

MRI 143
article thumbnail

iCAD Unveils ProFound Cloud, Enabling Interoperability and Access to Breast AI Solutions at Enterprise Scale

Imaging Technology

milla1cf Tue, 04/02/2024 - 18:41 April 2, 2024 — iCAD, Inc. , a global leader in clinically proven AI -powered cancer detection solutions, announced commercial availability of ProFound Cloud. The innovative Software-as-a-Service (SaaS) platform provides medical providers with a cost-effective, secure, and scalable means to access and deploy the latest ProFound Breast Health Suite of AI solutions.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Transforming Healthcare for the Future

MRI Network

The global healthcare sector is undergoing a period of unprecedented transformation, driven by technological advancements, demographic shifts, and evolving patient needs. Among the chief concerns is the looming shortfall in healthcare workers. This is a trend that MRI Network recruiters who specialize in healthcare have been addressing even before the need became so acute, filling more than a thousand positions over the past two years.

article thumbnail

GE HealthCare Closes MIM Software Acquisition

Imaging Technology

milla1cf Tue, 04/02/2024 - 18:51 April 2, 2024 — Less than three months after signing an agreement to acquire MIM Software Inc. , GE HealthCare Technologies Inc. announced the acquisition’s close and addition of MIM Software’s imaging analytics and digital workflow solutions as a part of its leading global medical technology, pharmaceutical diagnostics, and digital portfolio.

article thumbnail

Testing Innovations in Cancer: How to evaluate and use new technologies

Amidst rising cancer prevalence and soaring costs, new cancer technologies and innovations are emerging to support the early detection, treatment, and surveillance of cancer. Read this guide to understand how to evaluate these solutions for your employees and members – and to learn more about the current state of coverage, clinical and cost effectiveness, and impact on quality and outcomes.

article thumbnail

Five-Year Study Shows Significant Overuse of CT Angiography in the ER

Diagnostic Imaging

Researchers noted a 67.4 percent increase in head and neck CT angiography and a 38 percent reduction in findings of acute pathology in a recent comparison of 2017 and 2021 statistics for headache and/or dizziness presentations at the emergency department of an urban academic medical center.

Medical 87

More Trending

article thumbnail

Are Prostate Biopsies Necessary in Patients with Negative or Equivocal MRIs and Low PSA Density?

Diagnostic Imaging

Up to 48 percent of unnecessary prostate biopsies could be eliminated by limiting biopsy to patients with PI-RADS 4 and higher MRI assessments and a prostate-specific antigen density level below 0.15 ng/mL2, according to a new meta-analysis.

MRI 82
article thumbnail

Study finds AI empowers patients before and after seeing physicians for radiation oncology treatment

Medical Xpress: Radiology

Cancer patients about to undergo radiation oncology treatment have lots of questions. Could ChatGPT be the best way to get answers?

article thumbnail

Machine learning approach may help tailor precision medicine treatments

Health IT Analytics

New machine learning tool uses data on individualized molecular interactions to predict how a patient’s immune system will respond to foreign cells.

68
article thumbnail

Minimally invasive procedure may spare patients from thyroid surgery

Medical Xpress: Radiology

In a 10-center study, microwave ablation offered progression-free survival rates and fewer complications than surgery in the treatment of a form of thyroid cancer known as papillary thyroid carcinoma (PTC), according to research published in Radiology.

article thumbnail

Maximize Your Radiology Center’s Performance With Specialized Scheduling

Patient-centric scheduling can only be achieved through optimized radiology workflows, effective communications between staff and physicians, and, of course, through specialized schedulers. In this guide, we’ll take you through a step-by-step process to transform your radiology center into a high-performance hub of medical imaging.

article thumbnail

A Spear With Two Sides: The Unique Responsibility of Recruiters w/Michael Clegg

MRI Network

In most industries, you either occupy the supply side or the demand side of the equation. Recruiters don’t. We’re the tip of the spear on two sides and equally responsible to the hiring authorities and the talent. Fail to keep both sides sharp and focus too heavily on one side? We won’t be able to efficiently and predictably connect talented individuals to great organizations.

52
article thumbnail

New Whole-Body Imaging Technology Makes It Possible to View Inflammation on MRI Scan

MedImaging Radiography

Researchers are developing and clinically testing MRI and PET technologies that can noninvasively examine and quantify immune cells present in tumors.

MRI 52
article thumbnail

Hyperpolarized Imaging Techniques for the Kidney, Brain, and Pancreas

UCSF Biomedical Imaging

Hyperpolarized MRI Technology Resource Center highlight new methods to better image cancer in the kidney, brain, and pancreas.

Imaging 52
article thumbnail

Delayed n-Butyl-2-Cyanoacrylate Reflux upon Wedged Catheter Withdrawal after Pseudoaneurysm Embolization

JVIR

n-Butyl-2-cyanoacrylate (nBCA), frequently used as a neurointerventional embolic agent, has also been proven useful in peripheral applications (1,2). However, specific training and extensive experience are required because of the complexities associated with its dilution, delivery, and prevention of nontarget embolization (1). This report describes a case of unexpected delayed nBCA backflow during catheter withdrawal after pseudoaneurysm embolization.

IT 40
article thumbnail

The Employers Guide to Controlling Cancer

About 40% of us will be diagnosed with cancer in our lifetime, and patients are getting younger. At the same time, the cost of treatment continues to rise, with employers spending 8.5% more on cancer care for each employee than they did last year. The best thing employers can do for their employees and business tomorrow is to invest in cancer detection and care today.